.png)
Agenzia Italiana del Farmaco
home
Highlights
-
15 Oct 2025
Information and communication
The AIFA Activity Report Is Now Online
The report presents key data and activities from 2024, with comparisons to the previous two years.
-
09 Oct 2025
Press releases
Medicines approved for reimbursement by the AIFA Board of Directors. These include two new molecules, three generics, three biosimilars and an extension of therapeutic indication
Green light for the reimbursement of the first subcutaneous treatment for paroxysmal nocturnal haemoglobinuria and the first three biosimilars of denosumab, the monoclonal antibody indicated for osteoporosis and bone loss.
-
23 Sep 2025
Press releases
Use of paracetamol during pregnancy: European recommendations confirmed
The Italian Medicines Agency (AIFA) reports that, in light of the latest scientific assessments carried out at European level, there is no new evidence requiring changes to the current recommendations.
-
22 Sep 2025
Press releases
AIFA monitoring of pharmaceutical expenditure January-April 2025
Spending on medicines purchased directly by the Regions slows down.
News
03 Sep 2025
The Agency
Telephone switchboard service and FarmaciLine toll-free number (update)
20 Oct 2025
Monitoring Registers
Hepatitis C: update of 20 October 2025 concerning enrolled patients
15 Oct 2025
Transparency Lists
AIFA updates the Transparency Lists
15 Oct 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Nifedicor
09 Oct 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Crysvita (burosumab)
09 Oct 2025
Safety of medicinal products
Direct Healthcare Professional Communication (DHPC) on Caspofungin
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
